"Propranolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
| Descriptor ID |
D011433
|
| MeSH Number(s) |
D02.033.100.624.698.711 D02.033.755.624.698.711 D02.092.063.624.698.711 D02.455.426.559.847.638.945 D04.615.638.945
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Propranolol".
Below are MeSH descriptors whose meaning is more specific than "Propranolol".
This graph shows the total number of publications written about "Propranolol" by people in this website by year, and whether "Propranolol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 2 | 3 |
| 2000 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Propranolol" by people in Profiles.
-
Biswas S, Toro M, Horgan R, McLaren RA, Berghella V, Al-Kouatly HB. Propranolol to decrease time to delivery: a meta-analysis of randomized controlled trials. Am J Obstet Gynecol MFM. 2024 10; 6(10):101459.
-
Orrey DC, Halawa OI, Bortsov AV, Shupp JW, Jones SW, Haith LR, Hoskins JM, Jordan MH, Bangdiwala SI, Roane BR, Platts-Mills TF, Holmes JH, Hwang J, Cairns BA, McLean SA. Results of a pilot multicenter genotype-based randomized placebo-controlled trial of propranolol to reduce pain after major thermal burn injury. Clin J Pain. 2015 Jan; 31(1):21-9.
-
O-Uchi J, Lopes CM. Combined blockade of ?- and a1-adrenoceptors in left ventricular remodeling induced by hypertension: beneficial or not? Hypertens Res. 2010 Oct; 33(10):984-5.
-
Shao J, Kaushal G. Normal flora: living vehicles for non-invasive protein drug delivery. Int J Pharm. 2004 Nov 22; 286(1-2):117-24.
-
Shimizu W, Antzelevitch C. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol. 2000 Mar 01; 35(3):778-86.
-
Chugani DC, Niimura K, Chaturvedi S, Muzik O, Fakhouri M, Lee ML, Chugani HT. Increased brain serotonin synthesis in migraine. Neurology. 1999 Oct 22; 53(7):1473-9.
-
Burashnikov A, Antzelevitch C. Differences in the electrophysiologic response of four canine ventricular cell types to alpha 1-adrenergic agonists. Cardiovasc Res. 1999 Sep; 43(4):901-8.
-
Shimizu W, Antzelevitch C. Differential response of transmural dispersion of repolarization and torsade de pointes to beta-adrenergic agonists and antagonists in three models of the long QT syndrome. J Electrocardiol. 1999; 32 Suppl:150.
-
Shehata AR, Gillam LD, Mascitelli VA, Herman SD, Ahlberg AW, White MP, Chen C, Waters DD, Heller GV. Impact of acute propranolol administration on dobutamine-induced myocardial ischemia as evaluated by myocardial perfusion imaging and echocardiography. Am J Cardiol. 1997 Aug 01; 80(3):268-72.
-
Koo HP, Macarak EJ, Zderic SA, Duckett JW, Synder HM, Levin RM. The ontogeny of bladder function in the fetal calf. J Urol. 1995 Jul; 154(1):283-7.